Vertex Pharmaceuticals Incorporated (LON:0QZU)
London · Delayed Price · Currency is GBP · Price in USD 469.86
-10.45 (-2.18%)
At close: Jul 11, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 89.00 billion as of July 16, 2025. Its market cap has decreased by -7.70% in one year.
Market Cap
89.00B
Enterprise Value
81.75B
Revenue
8.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
469.86
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 89.00B, an increase of 173,695.83%. That is a compound annual growth rate of 24.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| GSK plc | 57.64B |
| Haleon | 32.99B |
| Smith & Nephew | 9.79B |
| ConvaTec Group | 5.29B |
| Hikma Pharmaceuticals | 4.35B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.47B |